相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model
Roque Diaz et al.
BMC CANCER (2010)
FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol
Rakesh K. Srivastava et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Structure of the FoxM1 DNA-recognition domain bound to a promoter sequence
D. R. Littler et al.
NUCLEIC ACIDS RESEARCH (2010)
Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma
Norio Kondo et al.
ONCOLOGY REPORTS (2010)
Angiogenesis and Lymphangiogenesis of Gastric Cancer
Yasuhiko Kitadai
JOURNAL OF ONCOLOGY (2010)
Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy
Dariusz Pytel et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2009)
Foxo1 is essential for in vitro vascular formation from embryonic stem cells
Seung-Hwan Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3
Amanda Nordigarden et al.
BLOOD (2009)
VEGFs and receptors involved in angiogenesis versus lymphangiogenesis
Marja Lohela et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
The role of angiogenesis in solid tumours: An overview
Nektaria Makrilia et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2009)
The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors
Lokesh Jain et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
Ursula B. McGovern et al.
MOLECULAR CANCER THERAPEUTICS (2009)
FOXO3a turns the tumor necrosis factor receptor signaling towards apoptosis through reciprocal regulation of c-Jun N-terminal kinase and NF-kappa B
Hae-Young Lee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
FoxM1B Transcriptionally Regulates Vascular Endothelial Growth Factor Expression and Promotes the Angiogenesis and Growth of Glioma Cells
Yujian Zhang et al.
CANCER RESEARCH (2008)
Resist or die FOXO transcription factors determine the cellular response to chemotherapy
Ana R. Gomes et al.
CELL CYCLE (2008)
VEGF polymorphisms and survival in early-stage non-small-cell lung cancer
Rebecca Suk Heist et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The forkhead transcription factor FOXO3a increases phosphoinositide-3 kinase/Akt activity in drug-resistant leukemic cells through induction of PIK3CA expression
Rosaline C. -Y. Hui et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells
Silvia Fernandez de Mattos et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression
Jimmy M-M. Kwok et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells
Rosaline C-Y. Hui et al.
MOLECULAR CANCER THERAPEUTICS (2008)
S-nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons
Alexi Nott et al.
NATURE (2008)
A brief introduction to FOXOlogy
Bmth Burgering
ONCOGENE (2008)
FOXO animal models reveal a variety of diverse roles for FOXO transcription factors
K. C. Arden
ONCOGENE (2008)
Many forks in the path: cycling with FoxO
K. K. Ho et al.
ONCOGENE (2008)
FOXOs, cancer and regulation of apoptosis
Z. Fu et al.
ONCOGENE (2008)
OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins
Kenneth Maiese et al.
TRENDS IN MOLECULAR MEDICINE (2008)
The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cells
Janna Krol et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The emerging roles of forkhead box (Fox) proteins in cancer
Stephen S. Myatt et al.
NATURE REVIEWS CANCER (2007)
ErbB receptors: from oncogenes to targeted cancer therapies
Hongtao Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Dynamic FoxO transcription factors
Haojie Huang et al.
JOURNAL OF CELL SCIENCE (2007)
Induction of Mxi1-SRα by FOXO3a contributes to repression of Myc-dependent gene expression
Oona Delpuech et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Delineation of molecular mechanisms of sensitivity to lapatinib in breast cancer cell lines using global gene expression profiles
Priti S. Hegde et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosis
Tatsuro Yamaguchi et al.
CANCER SCIENCE (2007)
Lapatinib: a dual inhibitor of EGFR and HER2 tyrosine kinase activity
Filippo Montemurro et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Drug Insight: VEGF as a therapeutic target for breast cancer
Bryan P. Schneider et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Phosphoinositide 3-kinase signalling and FoxO transcription factors in rheumatoid arthritis
K. A. Reedquist et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
FOXO transcription factors: key regulators of cell fate
E. W-F. Lam et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
The antitumor effects of sunitinib (formerly SU11248) against a variety of human hematologic malignancies: enhancement of growth inhibition via inhibition of mammalian target of rapamycin signaling
Takayuki Ikezoe et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Effect of SU11248 on gastrointestinal stromal tumor-T1 cells: Enhancement of growth inhibition via inhibition of 3-kinase/Akt/mammalian target of rapamycin signaling
Takayuki Ikezoe et al.
CANCER SCIENCE (2006)
Lapatinib: A novel dual tyrosine kinase inhibitor with activity in solid tumors
MH Nelson et al.
ANNALS OF PHARMACOTHERAPY (2006)
Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-jun NH2-Terminal kinase and Akt
A Sunters et al.
CANCER RESEARCH (2006)
A small-molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN)
Erika Rosivatz et al.
ACS CHEMICAL BIOLOGY (2006)
Progestins regulate the expression and activity of the forkhead transcription factor FOXO1 in differentiating human endometrium
S Labied et al.
MOLECULAR ENDOCRINOLOGY (2006)
Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells
A Essafi et al.
ONCOGENE (2005)
Genomic maps and comparative analysis of histone modifications in human and mouse
BE Bernstein et al.
CELL (2005)
Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice
T Furuyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells
S Lentzsch et al.
LEUKEMIA (2004)
FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism
SF de Mattos et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
FoxO3a transcriptional regulation of bim controls apoptosis in paclitaxel-treated breast cancer cell lines
A Sunters et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Epidermal growth factor receptor tyrosine kinase inhibitors
AE Wakeling
CURRENT OPINION IN PHARMACOLOGY (2002)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
分享论文
